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Kaare Christensen1,2,3
The analysis of age-specific genetic effects on human survival over extreme ages is confronted with a deceleration pattern in
mortality that deviates from traditional survival models and sparse genetic data available. As human late life is a distinct phase
of life history, exploring the genetic effects on extreme age survival can be of special interest to evolutionary biology and health
science. We introduce a non-parametric survival analysis approach that combines population survival information with individual
genotype data in assessing the genetic effects in cohort-based longitudinal studies. Our approach is characterized by non-
parametric analysis of late age survival to capture the observed pattern of mortality deceleration and frailty modeling to account
for individual heterogeneity in unobserved frailty. The method is applied to ApoE genotype data in the Danish 1905 birth cohort
to estimate effect of the e4 allele. Our results revealed an age-specific relative risk of the allele that increases nonlinearly with
age and non-proportional patterns in hazard of death for carriers and non-carriers of the allele, suggesting that the e4 mutation
preserves its deleterious effect that progressively affect human survival even at extreme ages.
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INTRODUCTION
The evolutionary theory of aging assumes that the effect of a gene
could change over an individual’s life course as genetic mutation
functioning at late ages are subject to weaker selection than early-acting
mutations.1 The age-specific genetic effects have been shown to affect
fitness traits in animal models.2 In humans, age-specific effects of
genetic variations have been reported to influence body mass index,3
blood pressure4,5 and survival.6 At late life, the force of natural selection
during the reproductive period stops. In term of survival, mortality
deviates significantly from the popular Gompertz model with a reliable
attribute characterized by deceleration in age-specific mortality rates.7
The paradoxical ‘plateaued’ mortality pattern implies that late life is a
distinct phase of life history8 for which exploring the genetic effects can
be of special interest to evolutionary biology and health science.
The estimation of an age-dependent genetic effect on survival can
often be confounded by differential life course exposure to environ-
mental factors or the birth cohort effect in age-structured popula-
tions.9 For that reason, a good choice is to conduct a follow-up or
longitudinal study on a birth cohort, which has only been feasible in
animal experiments. In human studies, however, longitudinal analysis
on genetic association with human longevity can be done with old-
aged birth cohorts, for example, the Danish 1905 birth cohort,10 to
look for genes that affect extreme age survival.9,11,12 Although of great
interest, estimating genetic effects on late life survival is confronted
with the distinct mortality pattern and sparse genetic data available.
In the literature, different theories or models have been proposed to
explain the late life-mortality pattern,8 among them the heterogeneity
model,13 which assumes individual heterogeneity in unobserved
frailty that follows a gamma distribution. Jacobsen et al11 applied a
Cox regression model with gamma-distributed frailty to the Danish
1905 birth cohort data to estimate the age-dependent effect on
extreme age survival for the ApoE gene, the only gene whose role on
longevity has been consistently demonstrated.14 This paper introduces
a demographic heterogeneity model that combines sparse individual
genotype data with population survival information to measure age-
specific genetic effect on survival at advanced ages. The method is
applied to ApoE genotype data from the Danish 1905 birth cohort10
to illustrate the patterns of the age-specific effect of the e4 allele in
affecting extreme age survival. Results with and without consideration
of unobserved frailty will be compared and genotype-specific
mortality patterns illustrated.
METHODS
For a given genetic variation, for example, a SNP, individuals can be grouped
according to their genotypes for a certain allele as non-carriers (0 allele),
heterozygous (1 allele) and homozygous (2 alleles) carriers based on which
effect of the allele can be assumed to be additive, dominant or recessive. For
simplicity, we divide individuals as carriers and non-carriers of the allele,
which is equivalent to a dominant assumption. In term of survival, the
population survival rate in a birth cohort is the weighted mean for allele
carriers (Z1 allele) and non-carriers (0 allele),15
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Here, sðxÞ is the mean survival rate in the birth cohort at age x, p is frequency
of carriers of the allele, s1(x) and so(x) are survival rates for carriers and non-
carriers of the allele. The relationship between s1(x) and s0(x) reflects relative
risk of the allele on survival. In a simple proportional hazard model, the
hazards of death corresponding to s1(x) and s0(x) are related as m1(x)¼ rm0(x)
such that
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The relationship above is based on the assumption that individuals are
homogenous except for their genotypes of the allele. However, in reality,
individuals are heterogeneous in their unobserved factors or frailty, including
genetic make-ups, which serves as the basis for existing theories that explain
mortality deceleration at advanced ages, among which is the demographic
heterogeneity theory by Vaupel et al.13 It follows that, when an individual’s
unobserved frailty designated as z is gamma-distributed with mean 1 and
variance s2, instead of (2), the relationship between s1(x) and s0(x) becomes
s1ðxÞ¼ ð1 rs2 ln s0ðxÞÞ 1/s
2
s0ðxÞ¼ ð1 s2 ln s0ðxÞÞ 1/s
2
:
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s0(x) is a homogenous baseline survival function. Note that the integration of (3)
with (1) combines population survival with genotype frequency and relative
risk parameters, which allows assessment of genetic effect on survival.
Based on (1), the proportions of carriers and non-carriers of
the allele at any age x can be estimated as p1ðxÞ¼ ps1ðxÞ/sðxÞ and
p0ðxÞ¼ ð1 pÞs0ðxÞ/sðxÞ¼ 1 p1ðxÞ, respectively. When genotype data is
available for a random sample from the cohort, a likelihood function based
on binomial distribution can be constructed at each age x as
LLðxÞ / n1ðxÞ log p1ðxÞþ n0ðxÞ log p0ðxÞ
/ n1ðxÞ log pþ log s1ðxÞ log sðxÞ½ 
þ n0ðxÞ logð1 pÞþ log s0ðxÞ log sðxÞ½ 
ð4Þ
In (4), n1(x) and n0(x) are the number of counts for carriers and non-carriers
of the allele at age x, p is proportion of carriers in the population, which can be
available for specific populations and sðxÞ is population survival rate at age x
obtainable from population statistics. With known sðxÞand p, (4) can be
maximized to estimate the relative risk on survival for carrying the allele. In a
longitudinal study on a birth cohort, (4) can be done for each age or year of
follow-up so that age-specific effects can be estimated. The maximum
likelihood estimation (MLE) is obtained by introducing a constraint as
specified in (1) and optimization of (4) with numerical gradient and Hessian.
Note that our MLE is free from specification of any parametric form for the
survival function and is thus a non-parametric approach. In addition, it
combines or makes use of population data in the analysis of genetic effect.
Moreover, genotype-specific survival or mortality rates can be calculated at
each age to further illustrate the genetic influence on mortality at advanced
ages.
Finally, our model allows analysis of sex-specific effect16 by simply replacing
the mean cohort survival in (1) with survival rate for males or females and
performing the analysis for each sex separately. However, because most of the
survivors at extreme ages are females, insignificant results in males due to small
sample sizes available may not necessarily mean sex-specific effect. In this case,
a combined analysis should be preferred.
RESULTS
We applied our method to the ApoE genotype data collected on 2662
individuals (584 males and 2078 females) from the Danish 1905 birth
cohort10 collected in a longitudinal survey initiated in 1998. All
participants were genotyped at age 92–93 years. Individual survival
information has been collected with the latest update at the end of
2010 when 10 subjects were still alive with their ages over 104 or 105.
For the entire 1905 birth cohort, cohort-specific survival information
is available from the Human Mortality Database at http://www.
mortality.org/ jointly hosted by University of California, Berkeley, and
the Max Planck Institute for Demographic Research, Rostock,
Germany. For the ApoE gene, frequency for the allele of interest,
that is, the e4 allele, was estimated to be 0.174 in the Danish
population,17 which corresponds to a carrier frequency of 0.318. As a
‘thrifty’ allele,18 carriers of e4 have been shown to have a higher
susceptibility to cardiovascular and Alzheimer’s diseases, and are
associated with higher mortality as compared with non-carriers under
the contemporary environmental condition.17,19 As such, frequency of
the allele is expected to decrease with increasing age in a birth cohort.
In our genotype data for the 1905 birth cohort, it is interesting to see
that the deceasing pattern continues even at extreme ages starting
with 21.7% at age 93 until 7.8% at age 104, a rapid decrease of about
14% in 11 years (Figure 1). The declining nonlinear pattern in e4
allele frequency that accelerates with age gives a clear indication of a
deleterious effect of the allele on human extreme age survival, which
needs to be characterized or measured by proper statistical models.
With known population survival for the entire 1905 birth cohort
and frequency of e4 allele in the Danish population, we first fitted the
likelihood function in (4) without frailty using genotype-specific
survival as defined in (2). For each age x, our procedure estimated an
age-specific relative risk on surviving from age x to xþ 1 (Table 1).
Our results showed that the estimated risks were all significantly
different from one over all ages with a slight trend of increase at later
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Figure 1 Frequency of e4 allele carriers in the 2662 subject from the 1905
birth cohort starting from age 93 until age 104. There is a clear pattern of
rapid decline as age increases, suggesting the increased risk of the allele on
survival over advanced ages.
Table 1 Estimated relative risk for e4 allele carriers with and without
consideration of heterogeneity
No frailty Frailty
Age Relative risk SE P-value Relative risk SE P-value
93 1.182 0.026 0.000 1.215 0.032 0.000
94 1.166 0.024 0.000 1.198 0.030 0.000
95 1.161 0.025 0.000 1.195 0.031 0.000
96 1.152 0.026 0.000 1.187 0.033 0.000
97 1.145 0.029 0.000 1.181 0.035 0.000
98 1.147 0.033 0.000 1.187 0.039 0.000
99 1.155 0.039 0.000 1.201 0.046 0.000
100 1.176 0.053 0.000 1.235 0.057 0.000
101 1.215 0.064 0.000 1.297 0.082 0.000
102 1.211 0.084 0.001 1.298 0.103 0.004
103 1.222 0.110 0.009 1.322 0.141 0.022
104 1.245 0.120 0.026 1.369 0.198 0.062
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ages. Figure 2a plots the estimated age-specific relative risks together
with their 95% confidence intervals. The figure clearly displays the
increasing risk for the e4 allele in the oldest survivors. The highest risk
of 1.23 (P¼ 0.026) was obtained at the highest age of 104. We
continued our analysis with frailty modeling by introducing gamma-
distributed frailty with mean of 1 and variance of 0.1 (according to
our experience in fitting frailty models to oldest-old mortality). From
the estimated relative risks (Table 1), one could see that the frailty
model gives higher risk estimates as compared with the no frailty
model. In addition to the increased risk, the age-dependent increase
in risk estimates is more clearly seen with frailty modeling, although
the overall pattern of increase remained (Figure 2b).
Using the relationships in (2) and (3), age-specific survivals for
carriers and non-carriers of the e4 allele can be calculated with the
estimated relative risk and baseline survival rate. This allows calcula-
tion of age-specific hazard rate m(x) because m(x)¼ d(ln s(x))/dx .
In Figure 3, we show the non-parametric age-specific hazard
functions for the total population starting from age 80 (solid line)
and the e4 allele carriers (dashed line) and non-carriers (dash-dotted
line) starting from age 93. Although mortality patterns for carriers
and non-carriers followed the main pattern of the whole cohort,
carriers had higher whereas non-carriers had lower instant probability
of death than that for the mean population, and overall this deviation
grew larger at later ages. Moreover, the population mortality pattern
in Figure 3 also exhibits the mortality leveling-off at high ages,
suggesting the necessity of frailty modeling.
Note that the calculated patterns of genotype-specific hazards were
the same for both frailty and no frailty models as optimization of (4)
was done for each age, however, the genetic risk was underestimated
when unobserved heterogeneity in frailty is ignored.
Finally, we applied the frailty model to another example for SNP
rs2764264 in the FOXO3A gene. The SNP was first reported to show
association with human longevity in a case–control study conducted
in the Italian population.20 Recently, the SNP was tested in both case–
control samples and the Danish 1905 cohort with the significant
association replicated only in the case–control samples.21 In Figure 4,
we show age-specific risks estimated from our frailty modeling
(frequency of carriers of minor allele set to 0.495 according to
Soerensen et al21). Different from the e4 all of ApoE gene, no risk
estimate in Figure 4 reached statistical significance, although there is a
slight trend toward a protective effect similar to that reported in the
literature in case–control studies.20,21
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Figure 2 Estimated age-specific relative risks for carrying the e4 allele over extreme age survival with 95% confidence intervals, which deviate from
constant and increase slightly over ages. Risk estimates without (a) and with (b) consideration of unobserved heterogeneity show obvious underestimation by
the former, suggesting the necessity of frailty modeling.
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Figure 3 Age-specific hazards of death for the whole 1905 birth cohort
starting from age 80 (solid line) and e4 allele carriers (dashed line) and
non-carriers (dash-dotted line) starting from age 93. The genotype-specific
mortality deviates remarkably from proportional.
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Figure 4 Age-specific relative risks for carrying minor allele of SNP
rs2764264 in the FOXO3A gene estimated with consideration of
unobserved heterogeneity. No risk estimate reached statistical significance,
although there is a slight trend of protective effect.
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DISCUSSION
The cohort study is deemed as the most ideal design for assessing risk
factors that affect human longevity9 and in characterizing their age-
specific effects. In humans, longitudinal following up for survival
analysis is only feasible in very old cohorts, such as the Danish 1905
birth cohort. However, at advanced ages, human survival is
characterized by mortality deceleration, which challenges
conventional survival models.8 We introduced a non-parametric
survival analysis that combines population survival information
with individual genotype data in estimating the genetic effects on
human longevity. Our method conducts frailty modeling by
introducing the simple gamma frailty model. Our comparison with
a model that ignores unobserved heterogeneity showed
underestimated genetic effect by the latter, which emphasizes the
importance of frailty modeling in genetic risk assessment at advanced
ages. The constraint likelihood for parameter estimation integrates
population data with individual genotype data and allows non-
parametric estimation of genetic risk parameters and the baseline
survival function to avoid specification of parametric survival models
that deviate from the observed mortality pattern. In addition to
parameter estimation, our procedure also calculates non-parametric
genotype-specific hazard of death over the observed ages to allow
comparison with population mean death rate (Figure 3).
Our likelihood-based procedure is made possible by restricting
estimation on each age separately. As an advantage, this allows
measurement of age-specific genetic effect. As shown by Figure 2,
the age-specific pattern of the estimated genetic risk deviates clearly
from being constant or linear, which contradicts to the proportional
hazard assumption. From the hazard functions for carriers and non-
carriers of e4 allele, one can easily see that they are far from
proportional. Such a pattern will be missed by traditional survival
analysis, such as the Cox’s proportional hazard model. In Table 2, we
compare the different analyses that have been applied to the ApoE
genotype data in the 1905 cohort. The early analysis (with high
censoring rate of 17%) by Bathum et al22 (Table 2) obtained an
overall risk for e4 carriers, which was only borderline significant.
Jacobsen et al11 introduced Aalen’s additive hazards model,23 an
extended Cox model, to estimate age-dependent risk assuming
additive risks over age intervals. It is interesting that, when applied
to the same updated data set (censoring rate 4%), their analysis also
reported the increased effect of the e4 allele on longevity, although
their analysis was limited to three age intervals. In comparison, our
combined analysis of population and individual data enabled
estimation for each age until the age as high as 104 years such that
patterns of the mean genetic effects and genotype-specific mortality at
extreme ages can be examined (Table 2). It can be expected that, with
the rapid development in the SNP genotyping and genome sequen-
cing, more genetic data will be available for association analysis of
human extreme age survival for which proper statistical models can
contribute.
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